Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|April 9, 2020
Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell AutoimmunityJarno Honkanen, Arja Vuorela, Daniel Muthas, et al.Plos One|December 8, 2022
Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPDRania Dagher, Paul Fogel, Jingya Wang, et al.RMD Open|October 6, 2025
Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trialPatrick G Gavin, Erik L Allman, David Jayne, et al.Respiratory Research|March 26, 2025
Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPDKarl J Staples, Jodie Ackland, Sruthymol Lukose, et al.Nature|August 10, 2021
Rare variant contribution to human disease in 281,104 UK Biobank exomesQuanli Wang, Ryan S Dhindsa, Keren Carss, et al.Annals of the Rheumatic Diseases|April 3, 2024
Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trialsTina Baker, Hoda Sharifian, Paul J Newcombe, et al.Respiratory Research|January 30, 2025
NTHi killing activity is reduced in COPD patients and is associated with a differential microbiomeVancheswaran Gopalakrishnan, Ben Sparklin, Jung Hwan Kim, et al.Communications Biology|March 24, 2021
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosisRyan S Dhindsa, Johan Mattsson, Abhishek Nag, et al.ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.Nature Reviews. Drug Discovery|February 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.Pageof 4